|
NL280825A
(https=)
*
|
1962-07-11 |
|
|
|
|
US3773919A
(en)
*
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
DE2010115A1
(de)
*
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
|
US4179337A
(en)
*
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4272398A
(en)
*
|
1978-08-17 |
1981-06-09 |
The United States Of America As Represented By The Secretary Of Agriculture |
Microencapsulation process
|
|
DE3685885D1
(de)
*
|
1985-01-16 |
1992-08-13 |
Ciba Geigy Ag |
Oligopeptide sowie zwischenprodukte und verfahren zu ihrer herstellung.
|
|
US5336489A
(en)
*
|
1985-09-05 |
1994-08-09 |
The Beth Israel Hospital Association |
Treatment of allograft rejection with IL-2 receptor-specific cytotoxins
|
|
US4627839A
(en)
*
|
1985-11-21 |
1986-12-09 |
American Hospital Supply Corporation |
Patient controlled analgesia conversion
|
|
US5023252A
(en)
*
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US4797285A
(en)
*
|
1985-12-06 |
1989-01-10 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
Lipsome/anthraquinone drug composition and method
|
|
US4764378A
(en)
*
|
1986-02-10 |
1988-08-16 |
Zetachron, Inc. |
Buccal drug dosage form
|
|
US5190761A
(en)
*
|
1986-08-05 |
1993-03-02 |
Liburdy Robert P |
Electromagnetic field triggered drug and chemical delivery via liposomes
|
|
US5690954A
(en)
*
|
1987-05-22 |
1997-11-25 |
Danbiosyst Uk Limited |
Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
|
|
ES2054784T3
(es)
*
|
1987-08-08 |
1994-08-16 |
Akzo Nv |
Un metodo para la fabricacion de un implante.
|
|
GB8822147D0
(en)
*
|
1988-09-21 |
1988-10-26 |
Ciba Geigy Ag |
Pharmaceutically active combination
|
|
US4938763B1
(en)
*
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
US5702716A
(en)
*
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
US5019400A
(en)
*
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
US5324519A
(en)
*
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
US5271961A
(en)
*
|
1989-11-06 |
1993-12-21 |
Alkermes Controlled Therapeutics, Inc. |
Method for producing protein microspheres
|
|
USRE37950E1
(en)
*
|
1990-04-24 |
2002-12-31 |
Atrix Laboratories |
Biogradable in-situ forming implants and methods of producing the same
|
|
CA2046830C
(en)
*
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
|
KR950007873A
(ko)
*
|
1993-09-20 |
1995-04-15 |
후꾸하라 요시하루 |
생리 활성 물질 지속 방출형의 의약 제제
|
|
JPH0789876A
(ja)
*
|
1993-09-20 |
1995-04-04 |
Shiseido Co Ltd |
徐放性製剤
|
|
ATE317690T1
(de)
*
|
1994-04-08 |
2006-03-15 |
Qlt Usa Inc |
Flüssige zusammensetzungen zur arzneistoffabgabe
|
|
US5958877A
(en)
*
|
1995-05-18 |
1999-09-28 |
Wimalawansa; Sunil J. |
Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide
|
|
ES2233768T3
(es)
*
|
1996-02-02 |
2005-06-16 |
Alza Corporation |
Liberacion prolongada de un agente activo utilizando un sistema implantable.
|
|
US5910482A
(en)
*
|
1996-03-19 |
1999-06-08 |
Board Of Regents, The University Of Texas System |
Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor
|
|
US5820589A
(en)
*
|
1996-04-30 |
1998-10-13 |
Medtronic, Inc. |
Implantable non-invasive rate-adjustable pump
|
|
US5792477A
(en)
*
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
|
US6086582A
(en)
*
|
1997-03-13 |
2000-07-11 |
Altman; Peter A. |
Cardiac drug delivery system
|
|
CA2305621C
(en)
*
|
1997-10-03 |
2009-01-20 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6201072B1
(en)
*
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
ATE262926T1
(de)
*
|
1998-01-29 |
2004-04-15 |
Poly Med Inc |
Asorbierbare mikropartikel
|
|
AR014069A1
(es)
*
|
1998-01-29 |
2001-01-31 |
Kinerton Ltd |
Procedimiento para preparar microparticula o microparticulas unidas encapsuladas
|
|
FR2776520B1
(fr)
*
|
1998-03-25 |
2000-05-05 |
Sod Conseils Rech Applic |
Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
|
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
|
JP4383674B2
(ja)
*
|
1998-12-31 |
2009-12-16 |
インターシア セラピューティクス，インコーポレイティド |
空間効率のよいピストンを有する浸透圧送達システム
|
|
CA2277656C
(en)
*
|
1999-07-19 |
2010-04-27 |
Imax Corporation |
Image projection system
|
|
DE60031999T2
(de)
*
|
1999-10-04 |
2007-06-06 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Stabilisierte flüssige polypeptid-haltige pharmazeutische zusammensetzungen
|
|
US6461631B1
(en)
*
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
US6589549B2
(en)
*
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US6809079B2
(en)
*
|
2002-01-08 |
2004-10-26 |
Vasogenix Pharmaceuticals, Inc. |
Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide
|
|
EP1496835A4
(en)
*
|
2002-02-01 |
2006-10-18 |
Omeros Corp |
COMPOSITIONS AND METHODS FOR THE SYSTEMIC SUPPRESSION OF CARTON DECOMPOSITION
|
|
EP1703895A2
(en)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Controlled release cgrp delivery composition for cardiovascular and renal indications
|
|
JP2007517911A
(ja)
*
|
2004-01-13 |
2007-07-05 |
バソジェニックス ファーマシューティカルズ， インコーポレイテッド |
心臓血管の適応症および腎臓の適応症に対してｃｇｒｐを使用する方法
|
|
CA2579646A1
(en)
*
|
2004-09-09 |
2006-03-16 |
Bayer Healthcare Llc |
Damping system for a lancet using compressed air
|